Frontiers
US$ 20.89
glp-1 drug market news today Size, Share The Multi-Sector Impacts of GLP-1RA
Description
Am J Med (2010) 123:468
CagriSema has completed Phase 3 trials and Novo Nordisk is expected to file for FDA approval
[DOI] [PMC free article] [PubMed] [Google Scholar] 137.Mller M.J., Bosy-Westphal A
check with your provider
doi: 10.1055/s-2004-826175 141 MeierJJGallwitzBSalmenSGoetzeOHolstJJSchmidtWEet al
